Dominique Remy-Renou
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Dominique Remy-Renou
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million.
19
| Holding Company | Medical Specialties | 19 |
| Public Company | Medical Specialties | 14 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Dominique Remy-Renou
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| C.R. BARD | Medical Specialties | Chief Executive Officer Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
General Atlantic LLC
 General Atlantic LLC Investment ManagersFinance General Atlantic LLC (General Atlantic) is a private equity firm founded in 1980 by Charles F. Feeney. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
| SANOFI | Biotechnology | Chief Tech/Sci/R&D Officer | |
Celera Corp.
 Celera Corp. Medical/Nursing ServicesHealth Services Celera Corp. provides medical diagnostics services. It offers disease management solutions through a combination of tests and services based on genetics discovery platforms. Celera was founded in 1998 and is headquartered in Alameda, CA. | Medical/Nursing Services | Corporate Officer/Principal General Counsel Chief Administrative Officer Corporate Officer/Principal | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
Arthur Andersen /Belgium/
 Arthur Andersen /Belgium/ Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Arthur Andersen /Belgium/ is a Belgian company that provides accounting services. The company is located in Belgium. The company was founded by Stéphane Verdood. Arthur Andersen /Belgium was acquired by Deloitte & Touche LLP from Arthur Andersen LLP on April 18, 2002. | Miscellaneous Commercial Services | Founder | |
| ACCURAY INCORPORATED | Medical Specialties | Chief Operating Officer Director/Board Member | |
| Eastern Washington University | College/University | Undergraduate Degree | |
| Simmons University | College/University | Undergraduate Degree | |
| University of California, Davis | College/University | Doctorate Degree | |
| University of Connecticut | College/University | Masters Business Admin Undergraduate Degree | |
| Université de Montpellier | College/University | Doctorate Degree | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Director of Finance/CFO | |
Celera Diagnostics LLC
 Celera Diagnostics LLC Medical/Nursing ServicesHealth Services Celera Diagnostics LLC discovers, develops and commercializes molecular diagnostics. The firm enables physicians to diagnose, monitor and treat disease. It manufactures products for infectious disease testing and for genetic conditions such as cystic fibrosis. The company was founded in 2001 by Kathy Ordoñez and is headquartered in Alameda, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
| The University of York | College/University | Chief Tech/Sci/R&D Officer | |
Ariana Pharmaceuticals SA
 Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Pharmaceuticals: Major | Founder | |
| École Nationale Supérieure des Mines de Paris | College/University | Undergraduate Degree | |
| Brooklyn Law School | College/University | Graduate Degree | |
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Medical/Nursing Services | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| EOS IMAGING | Medical Specialties | Director of Finance/CFO | |
| PHARNEXT SCA | Biotechnology | Director of Finance/CFO | |
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member President Corporate Officer/Principal | |
Vesalius Biocapital Arkiv NV
 Vesalius Biocapital Arkiv NV Investment ManagersFinance Vesalius Biocapital Arkiv NV focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project. Vesalius Biocapital Arkiv is part of the ARKImedes project which, is organized and/or managed by Participatiemaatschapij Vlaanderen NV. | Investment Managers | Corporate Officer/Principal | |
Vesalius Biocapital I SA SICAR
 Vesalius Biocapital I SA SICAR Investment ManagersFinance Vesalius Biocapital I SA Sicar focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project. | Investment Managers | Director/Board Member | |
| Vesalius Biocapital II Investments SA Sicar | Chairman | ||
Vesalius Biocapital II SA SICAR
 Vesalius Biocapital II SA SICAR Investment ManagersFinance Vesalius Biocapital II SA Sicar focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project. | Investment Managers | Director/Board Member | |
| Vesalius Biocapital II Partners SARL | Corporate Officer/Principal | ||
Vesalius Biocapital II Arkiv NV
 Vesalius Biocapital II Arkiv NV Investment ManagersFinance Vesalius Biocapital II Arkiv NV focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project. Vesalius Biocapital Arkiv is part of the ARKImedes project, which is organized and/or managed by Participatiemaatschapij Vlaanderen NV. | Investment Managers | Chief Executive Officer | |
Forendo Pharma Oy
 Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Director/Board Member | |
| Vesalius Biocapital II Holdings SARL | Chief Executive Officer | ||
| Sci Itzulika | Corporate Officer/Principal | ||
Genkyotex Innovation SAS
 Genkyotex Innovation SAS BiotechnologyHealth Technology Part of Calliditas Therapeutics AB, Genkyotex Innovation SAS engages in research and development of biotechnology. The company is based in Saint Julien-en-Genevois, France. | Biotechnology | Director/Board Member | |
Scenic Biotech BV
 Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands. | Miscellaneous Commercial Services | Director/Board Member | |
| Universite Paris Cite | College/University | Doctorate Degree Graduate Degree | |
| Vesalius Biocapital Iii Partners SARL | Director/Board Member | ||
| Vesalius Biocapital Iii SCA Sicar | Director/Board Member | ||
| Vesalius Biocapital Iii Investments SA Sicar | Director/Board Member | ||
| Vesalius Biocapital Iii Portugal SARL | Director/Board Member | ||
| INGERSOLL RAND INC. | Industrial Machinery | Director/Board Member | |
| Vesalius Biocapital III CMF UG | Director/Board Member | ||
Harbinger Health
 Harbinger Health Information Technology ServicesTechnology Services Harbinger Health, Inc. is a company based in Cambridge, MA. Harbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis, and management. The company combines advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic with the aim of developing a low-cost, multi-cancer blood test. Harbinger envisions a future where cancer could be kept from forming, making a cancer diagnosis a routine health problem to be addressed rather than a life-altering event to be feared with profound implications for people, healthcare systems, and societies. The company fundamentally transforms cancer care for everyone. The company was founded in 2020 by Alexander Meissner, Sidney Farber, Zachary Smith, Franziska Michor. The CEO is Stephen Hahn. | Information Technology Services | Director/Board Member | |
| OCEASOFT | Electronic Equipment/Instruments | Director of Finance/CFO |
Statistik
International
| Vereinigte Staaten | 21 |
| Frankreich | 13 |
| Luxemburg | 10 |
| Belgien | 5 |
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 15 |
| Consumer Services | 11 |
| Finance | 7 |
| Health Services | 4 |
| Commercial Services | 4 |
Operativ
| Director/Board Member | 111 |
| Corporate Officer/Principal | 86 |
| Independent Dir/Board Member | 29 |
| Undergraduate Degree | 24 |
| President | 18 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Stéphane Verdood | 32 |
| Arnold Levine | 30 |
| James Tobin | 26 |
| William V. Murray | 15 |
| Andrew Last | 15 |
| Dennis L. Winger | 15 |
| Mark Stevenson | 13 |
| Susan L. Koppy | 12 |
| William H. Longfield | 12 |
| Paul D. Arata | 11 |
| Theodore E. Martin | 10 |
| Chris Yoo | 10 |
| Stacey R. Sias | 10 |
| Elisabeth Ourliac | 10 |
| Beth Jacobs | 9 |
- Börse
- Insiders
- Dominique Remy-Renou
- Unternehmensverbindungen
